Just weeks after our debut as an independent, publicly traded company, Sandoz was named “Company of the Year” in the generics and biosimilar medicines industry. In recognition of his achievements at Sandoz and for the industry as a whole, Sandoz…
AstraZeneca announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the development of next generation therapeutics in areas of high unmet need, including oncology, immunology and rare diseases. Under the terms of the collaboration agreement,…
Bristol Myers Squibb announced that its Board of Directors has unanimously elected Christopher Boerner, Ph.D., to serve as Chair of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, M.D., who will step down as Chair of the Board…
Merck Healthcare today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui). The partnership includes an exclusive license worldwide (ex-China) to develop, manufacture and commercialize Hengrui’s next-generation potent and selective PARP1 (poly (ADP-ribose) polymerase 1) trapping inhibitor HRS-1167.…
Novartis today announced positive topline results from the interim analysis of the ongoing pivotal Phase 3 ALIGN study of atrasentan, an oral endothelin A receptor antagonist (ERA), in patients with IgAnephropathy (IgAN). The study met its primary efficacy endpoint at…
Boehringer Ingelheim now presents itself with a new corporate branding that is designed to inspire deeper connection with the company’s diverse customers, partners, and employees. The evolved brand includes several striking changes including the introduction of a standout color palette…
GSK today announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial investigating Jemperli (dostarlimab) plus standard-of-care chemotherapy (carboplatin and paclitaxel), followed by dostarlimab as a single agent, compared to placebo plus chemotherapy…
Otsuka Pharmaceutical Companies (U.S.) and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc. today announced positive results of two, 6-week, Phase 3 clinical trials that evaluated the efficacy, safety, and tolerability of centanafadine for the treatment of adolescents and…
Erasmus MC staff are teaming up with researchers from EUR and TU Delft to work on sustainable care. Within three research programmes, they are committed to sustainable operating rooms, endoscopy and innovation for nurses. The new sustainable programmes are SMART…
It started with one magical model, no dedicated space and a few staff who saw the transformative power of molded plastics, printed layer by layer into a physical, life-size anatomical representation. This 3D-printed replica of conjoined twins was the big…